English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Magnolia Market
F. L. Bell
| Jul 17, 2026
Community Action for Responsible Hospitals: 'Policymakers must require 340B covered entities to show where the money is going'
Trending
+
Pharmaceuticals
Patient Daily
| Aug 4, 2026
Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+
Regulatory
L. R. Alvarez
| Jul 30, 2026
TPA's Ross Marchand on 340B: 'Taxpayers are picking up the tab for the program's many failures and mission creep'
+
Pharmaceuticals
Patient Daily
| Jul 30, 2026
Jefferies analysts say Daiichi Sankyo’s pipeline lags as cash flow nears peak
+
Regulatory
M. R. Armstrong
| Aug 4, 2026
Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
